The American Cancer Society updates its guidelines on diet and physical activity, and a study projects that caring for Americans with cancer will cost more than $245 billion by 2030.

by Kate Yandell

Data show that some people with early-stage non-small cell lung cancer can benefit significantly from treatment with a targeted therapy, and COVID-19 slows the rate of enrollment in cancer clinical trials.

by Kate Yandell

COVID-19 slowed or stopped enrollment in some cancer clinical trials.

by Kate Yandell

Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.

by Kate Yandell